PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Aurora Cannabis hovers trade flat amid strong market

Aurora Cannabis hovers trade flat amid strong market

by PublicWire
August 13, 2019
in Cannabis
Reading Time: 2 mins read
0

The cannabis industry is mostly high on Tuesday with the exception of some like Aurora Cannabis that hovered over a stock flat after Piper Jaffray initiated coverage with a neutral rating, saying that the stocks are overvalued.

Aurora ACB, +1.59% ACB, +1.44% fell 1.1% in early trading but was able to recover into a trading flat in the midday and reverses its losses. The rating stands in contrast to the equivalent of buy rating (outperform) that Piper assigned to five other cannabis names it started coverage of Tuesday. Michael Lavery, who leads the analysts for Aurora, says that the company lacked visibility on parts of their long-term strategic checklist.

“Aurora has a premium valuation relative to peers but less visibility on these key growth opportunities,” Lavery wrote, referring to Canada, the European Union, and the U.S. CBD and U.S. THC markets. The latter two are ingredients in the cannabis plant; CBD is nonintoxicating but widely held to have wellness properties, while THC is the ingredient that causes the high associated with cannabis.

“It has leading scale in Canada, but oversupply looks likely in 2020,” the analyst wrote. “EU-GMP certification at scale is a slow, opaque process and still pending, and without visibility on U.S. market entry (CBD or THC), Aurora’s relatively rich valuation does not yet look compelling to us.”

Meanwhile, other pot companies are expected to perform well in the market in the next few days. Piper analysts believes, in contrast with Aurora, that Cronos CRON, +5.28%  , CRON, +5.49% will deliver a strong top-line growth.

“We believe its partnership with Altria MO, +1.74%  provides important capital ($1.8B cash) and access into 230,000 U.S. retail outlets, as well as regulatory and vapor product expertise,” said Lavery. “We expect Cronos to have modest near-term revenues from Canadian cannabis production, but believe it has significant potential growth opportunities with CBD products in the U.S., including through its pending acquisition of the Lord Jones brand.”

Previous Post

CBS, Viacom inks merger to reunite as ViacomCBS

Next Post

Japan is no longer a “trusted trading partner” of South Korea

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Photo by Botanical Rising on Unsplash
Cannabis

Canadian cannabis company Cronos rising in premarket stock by 8%

August 8, 2019
0
Next Post
Photo by Tianshu Liu on Unsplash

Japan is no longer a "trusted trading partner" of South Korea

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.